| Pharmaceutical active ingredients: |
| Nitroglycerin |
| Available forms, composition and doses of Willlong: |
| N / A |
| Willlong medical category: |
| Human:Anti-anginal drugsNitrates and nitrites |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C01DA02 - Glyceryl TrinitrateC05AE01 - Glyceryl Trinitrate |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Will-PharmaBJC Trading |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Olmes | Olmesartan Medoxomil | Will-Pharma |
| Rado-Salil | Camphor; Capsicum Oleoresin; Ethyl Salicylate; Glycol Salicylate; Menthol; Methyl Salicylate; Salicylic Acid | Will-Pharma |
| Rado-Spray | Glycol Salicylate; Lidocaine Hydrochloride; Methyl Nicotinate | Will-Pharma |
| Syngel | Aluminum Hydroxide-Magnesium Carbonate-Co Dried Gel; Lidocaine Hydrochloride; Magnesium Hydroxide; Magnesium Trisilicate | Will-Pharma |
| Trianal | Lidocaine Hydrochloride; Triamcinolone Acetonide | Will-Pharma |
| Willospon | Gelatin | Will-Pharma |
| Willospon Forte | Collagen | Will-Pharma |
| Actizyme | Poloxamer 338; Subtilisin A | Willvonseder & Marchesani |
| Aywet | Hydroxyethylcellulose; Poloxamer | Willvonseder & Marchesani |
| Dilydrin | Nylidrin Hydrochloride | Willvonseder & Marchesani |